TrialX
Image

Treatment of Anemia With Intravenous Iron in Patients Listed for Orthotopic Liver Transplantation

Treatment of Anemia With Intravenous Iron in Patients Listed for Orthotopic Liver Transplantation

Recruiting
18 years and older
All
Phase 4

Overview

The aim of this study is to investigate whether therapy with intravenous iron carboxymaltose in patients with iron deficiency anemia (IDA) listed for orthotopic liver transplantation (OLT) increases hemoglobin concentrations and reduces intraoperative transfusion of packed red blood cells (PRBCs). The investigators hypothesize that therapy with intravenous iron will increase hemoglobin concentrations and reduce intraoperative transfusion of PRBCs in patients with IDA listed for OLT.

Eligibility

Inclusion Criteria:

  • patients listed for OLT with positive screening for IDA

Exclusion Criteria:

  • Age <18 years
  • Hemochromatosis
  • Iron utilization disorders
  • Non-IDA
  • Therapy with erythropoietin-stimulating agents or intravenous iron within 4 weeks prior to screening
  • Previous allergic reactions against intravenous iron formulations
  • Transfusion within 2 weeks prior to screening
  • Complete portal vein thrombosis
  • High-urgency OLT
  • Pregnancy
  • Sepsis or severe infection
  • Immunosuppressive therapy

Study details
    Hemorrhage
    Hemorrhage
    Liver transplant
    Organ Transplantation

NCT04475887

Medical University of Vienna

5 August 2020

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.